Table 3.
OR (95% CI) by Multiple Logistic Regression Models for Metabolic Syndrome Components in Relation to Biomarkersa
Irisin (n = 148) |
Adiponectin (n = 146) |
|||||||
---|---|---|---|---|---|---|---|---|
T1, n = 49 | T2, n = 50 | T3, n = 49 | P for Trend | T1, n = 48 | T2, n = 49 | T3, n = 49 | P for Trend | |
MetS, n | 5/49 | 13/50 | 25/49 | 25/48 | 13/49 | 5/49 | ||
Model 1 | 1 | 3.09 (1.01–9.48) | 9.17 (3.11–27.0) | <.001 | 1 | 0.33 (0.14–0.78) | 0.11 (0.04–0.31) | <.001 |
Model 2 | 1 | 2.69 (0.84–8.59) | 9.80 (3.12–30.8) | <.001 | 1 | 0.26 (0.10–0.68) | 0.07 (0.02–0.24) | <.001 |
Model 3 | 1 | 2.46 (0.67–9.02) | 12.43 (3.42–45.2) | <.001 | 1 | 0.28 (0.10–0.78) | 0.07 (0.02–0.28) | <.001 |
WC,b n | 23/49 | 30/50 | 33/49 | 33/48 | 28/49 | 24/49 | ||
Model 1 | 1 | 1.70 (0.76–3.76) | 2.33 (1.03–5.29) | .04 | 1 | 0.61 (0.26–1.39) | 0.44 (0.19–0.999) | .05 |
Model 2 | 1 | 1.16 (0.68–4.06) | 2.78 (1.11–6.99) | .03 | 1 | 0.42 (0.16–1.11) | 0.21 (0.07–0.59) | .003 |
Model 3 | 1 | 2.64 (0.28–24.5) | 1.99 (0.22–17.7) | .58 | 1 | 0.54 (0.06–4.57) | 0.27 (0.03–2.53) | .25 |
BP,c n | 18/49 | 25/50 | 29/49 | 23/48 | 31/49 | 18/49 | ||
Model 1 | 1 | 1.77 (0.77–3.84) | 2.50 (1.11–5.63) | .03 | 1 | 1.87 (0.83–4.21) | 0.63 (0.28–1.42) | .80 |
Model 2 | 1 | 1.49 (0.59–3.72) | 3.15 (1.21–8.22) | .02 | 1 | 2.16 (0.84–5.58) | 0.44 (0.16–1.21) | .12 |
Model 3 | 1 | 1.31 (0.47–3.63) | 2.51 (0.91–6.88) | .07 | 1 | 3.12 (1.10–8.85) | 0.70 (0.22–2.21) | .59 |
Glucose,d n | 5/49 | 9/50 | 18/49 | 16/48 | 11/49 | 5/49 | ||
Model 1 | 1 | 1.93 (0.60–6.24) | 5.11 (1.71–15.2) | .002 | 1 | 0.58 (0.24–1.42) | 0.23 (0.08–0.69) | .007 |
Model 2 | 1 | 2.12 (0.62–7.28) | 6.04 (1.87–19.5) | .002 | 1 | 0.58 (0.22–1.52) | 0.22 (0.07–0.71) | .01 |
Model 3 | 1 | 1.80 (0.50–6.46) | 5.80 (1.72–19.6) | .003 | 1 | 0.65 (0.24–1.77) | 0.28 (0.08–0.95) | .04 |
TG,e n | 8/49 | 10/50 | 19/49 | 17/48 | 14/49 | 6/49 | ||
Model 1 | 1 | 1.28 (0.46–3.58) | 3.25 (1.25–8.4) | .001 | 1 | 0.73 (0.31–1.72) | 0.25 (0.09–0.72) | .01 |
Model 2 | 1 | 1.19 (0.35–4.04) | 4.23 (1.31–13.7) | .01 | 1 | 0.52 (0.18–1.48) | 0.14 (0.04–0.55) | .005 |
Model 3 | 1 | 0.97 (0.27–3.24) | 3.89 (1.16–13.0) | .02 | 1 | 0.55 (0.19–1.63) | 0.18 (0.04–0.73) | .02 |
HDL,f n | 9/49 | 18/50 | 23/49 | 26/48 | 14/49 | 8/49 | ||
Model 1 | 1 | 2.5 (0.99–6.31) | 3.93 (1.57–9.82) | .003 | 1 | 0.34 (0.15–0.78) | 0.17 (0.06–0.43) | <.001 |
Model 2 | 1 | 2.96 (1.09–8.0) | 4.82 (1.79–13.0) | .002 | 1 | 0.19 (0.07–0.50) | 0.07 (0.02–0.24) | <.001 |
Model 3 | 1 | 2.75 (1.002–7.54) | 4.56 (1.68–12.4) | .003 | 1 | 0.19 (0.07–0.53) | 0.08 (0.02–0.27) | <.001 |
Model 1 is unadjusted. Model 2 is adjusted for age, gender, race, smoking status, physical activity, vegetable or fruit consumption, and alcohol consumption. Model 3 is adjusted as for model 2 plus BMI. Tertile values of biomarkers are expressed as T1, T2, and T3. (For irisin [nanograms per milliliter]: T1, 72.19–157.09; T2, 157.1–209.00; T3, 209.01–749.34; and for adiponectin [micrograms per milliliter]: T1, 1.12–5.60; T2, 5.61–10.6; T3, 10.7–28.8).
WC ≥102 cm for men and ≥88 cm for women.
Systemic hypertension (BP ≥130/85 mm Hg) or antihypertensive therapy.
Elevated FPG (≥100 mg/dL) or history of diabetes mellitus or taking antidiabetic medications.
Elevated TG (≥150 mg/dL) or specific medication for elevated TG.
Low HDL-cholesterol (men, <40 mg/dL; women, <50 mg/dL) or specific medication for low HDL.